Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids

BMC Cardiovascular Disorders

Case Report

Gustav Mattsson¹  Peter Magnusson² 

[1] Centre for Research and Development, Uppsala University/Region Gävleborg, SE-801 87, Gävle, Sweden;Centre for Research and Development, Uppsala University/Region Gävleborg, SE-801 87, Gävle, Sweden;Cardiology Research Unit, Department of Medicine, Karolinska Institutet, SE-171 76, Stockholm, Sweden;

关键词: Cardiac imaging;    Cardiac magnetic resonance;    Cardiomyopathy;    Churg-Strauss;    Corticosteroids;    Echocardiography;    Eosinophilic granulomatosis with polyangiitis;    Heart failure;    Hypertrophy;    Myocardial thickening;   

DOI  :  10.1186/s12872-017-0734-8

 received in 2017-09-25, accepted in 2017-12-12,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundIn 1951 Churg and Strauss first described the clinical condition now known as eosinophilic granulomatosis with polyangiitis (EGPA), characterized by asthma, nasal polyposis, rhinosinusitis, hypereosinophilia with organ infiltration, and necrotizing vasculitis. It is classified as an antineutrophil cytoplasmic antibody (ANCA) associated vasculitis, but ANCA negativity is common and more frequently encountered in EGPA with myocardial involvement. Long-term survival has substantially improved with corticosteroid treatment but myocardial involvement is still the leading cause of death in EGPA.Case presentationA 53-year old man with a history of asthma and nasal polyposis presented with acute chest pain and elevated troponin; a percutaneous coronary intervention was performed. The left ventricle was described as hypertrophic. After 20 days the myocardium had markedly increased in thickness of both the right and left ventricle. Evaluation revealed hypereosinophilia in the blood and nasal mucosal tissue, which confirmed the diagnosis of EGPA. He presented with signs of active vasculitis including weight loss, tiredness, intracerebral hemorrhage, and increasing serum creatinine. After 6 days of corticosteroid treatment, the myocardium returned to its initial thickness.ConclusionRapid and marked thickening of the myocardium is not frequently reported but may occur in EGPA. Myocardial thickening in EGPA can be quickly reversed by corticosteroids, and is most likely caused by edema.

【 授权许可】

CC BY   
© The Author(s). 2017